Neuromorphic Computing in 2026: What Intel and IBM Have Built, and Why It Still Isn’t Mainstream

Neuromorphic Computing featured image

3 min readIntel’s Hala Point and IBM’s NorthPole deliver 22–100x energy efficiency gains over GPUs on specific sparse workloads — but no standard programming model, a thin software ecosystem, and narrow task compatibility have kept neuromorphic chips out of commercial AI deployments.

AI-Designed Drugs Are Entering Clinical Trials. The Pipeline Is Larger Than Most Engineers Realize.

AI Drug Discovery featured image

4 min readOver 150 AI-designed drug candidates are in clinical trials globally — a 7x increase since 2022. AlphaFold 3 has compressed pre-clinical discovery from 4–6 years to 12–24 months. The first FDA approvals of AI-primary drug candidates are 3–5 years away.

The Five AI Shifts That Actually Mattered in 2025

4 min read2025 will be remembered not for the volume of AI announcements but for five shifts that had real structural weight. Models got smarter, cheaper, and started taking action — but the more important story was what each shift revealed about where the field was actually heading.